以海豹油为基质的多西紫杉醇脂肪乳的制备及其抗肿瘤活性研究
发布时间:2019-06-22 13:42
【摘要】:目的制备精氨酸-甘氨酸-天冬氨酸-苯丙氨酸-十二烷基脂肪醇(arginine-glycine-aspartate-phenylalanine-dodecyl alcohols,RGDFOC12)介导的多西紫杉醇(docetaxel,DTX)脂肪乳简称RGDFOC12-DTX脂肪乳,并考察其抗肿瘤活性。方法以抗肿瘤药物DTX为模型药物,以海豹油为油相,卵磷脂为乳化剂,两亲性RGDFOC12为新型膜材,通过高压乳匀法制备RGDFOC12-DTX脂肪乳。并考察其粒径、Zeta电位、渗透压、离心率(Ke)、p H、包封率、体外释药行为和抗肿瘤作用效果。结果 RGDFOC12-DTX脂肪乳粒径在190~250 nm,Zeta电位在-30~-40 m V,渗透压在280~320 m Osm·L-1,0.50Ke0.70,p H在6.5~8.0,载药质量浓度为1 000 mg/L,包封率在90%以上。电镜下观察RGDFOC12-DTX脂肪乳粒子呈均匀球形。体外释放实验显示RGDFOC12-DTX脂肪乳呈缓释的特点,体外抗肿瘤活性实验显示,RGDFOC12-DTX脂肪乳对各细胞系有明显的时间依赖效应,且呈现出缓释的特点。体内抗肿瘤活性实验显示,RGDFOC12-DTX脂肪乳具有更好的抗肿瘤活性。结论本文报道了RGDFOC12-DTX脂肪乳的新剂型及制备方法,该剂型可有效增加药物的稳定性,降低注射时的刺激性,增强机体依从性且具有缓释性和更好的抗肿瘤活性。
[Abstract]:Objective to prepare arginine-glycine-aspartic acid-phenylalanine-lauryl fatty alcohol (arginine-glycine-aspartate-phenylalanine-dodecyl alcohols,RGDFOC12)-mediated docetaxel (docetaxel,DTX) fat emulsion for short RGDFOC12-DTX fat emulsion and to investigate its antitumor activity. Methods RGDFOC12-DTX fat emulsion was prepared by high pressure emulsion homogenization with DTX as model drug, seal oil as oil phase, lecithin as emulsifier and Amphiphilic RGDFOC12 as new membrane material. The particle size, Zeta potential, osmotic pressure, eccentricity (Ke), p H, entrapment efficiency, drug release behavior in vitro and antitumor effect were also investigated. Results the particle size of RGDFOC12-DTX fat milk was 190 脳 250 nm,Zeta potential at-30 Osm 路L-1, osmotic pressure was 280? 320 m Osm 路L-1, osmotic pressure was 0.50 Ke0.70, pH was 6.5? 8.0. the entrapment efficiency of 1000 mg/L, was over 90%. Under electron microscope, RGDFOC12-DTX fat emulsion particles were uniformly spherical. In vitro release test showed that RGDFOC12-DTX fat emulsion showed sustained release. In vitro antitumor activity test showed that RGDFOC12-DTX fat emulsion had obvious time-dependent effect on each cell line and showed sustained release. In vivo antitumor activity test showed that RGDFOC12-DTX fat emulsion had better antitumor activity. Conclusion A new dosage form and preparation method of RGDFOC12-DTX fat emulsion are reported in this paper. the dosage form can effectively increase the stability of the drug, reduce the irritation during injection, enhance the compliance of the body, and has sustained release and better antitumor activity.
【作者单位】: 首都医科大学化学生物学与药学院药剂系;
【基金】:“十二五”重大新药创制科技重大专项(2011ZX09302-007-01)~~
【分类号】:R943;R96
[Abstract]:Objective to prepare arginine-glycine-aspartic acid-phenylalanine-lauryl fatty alcohol (arginine-glycine-aspartate-phenylalanine-dodecyl alcohols,RGDFOC12)-mediated docetaxel (docetaxel,DTX) fat emulsion for short RGDFOC12-DTX fat emulsion and to investigate its antitumor activity. Methods RGDFOC12-DTX fat emulsion was prepared by high pressure emulsion homogenization with DTX as model drug, seal oil as oil phase, lecithin as emulsifier and Amphiphilic RGDFOC12 as new membrane material. The particle size, Zeta potential, osmotic pressure, eccentricity (Ke), p H, entrapment efficiency, drug release behavior in vitro and antitumor effect were also investigated. Results the particle size of RGDFOC12-DTX fat milk was 190 脳 250 nm,Zeta potential at-30 Osm 路L-1, osmotic pressure was 280? 320 m Osm 路L-1, osmotic pressure was 0.50 Ke0.70, pH was 6.5? 8.0. the entrapment efficiency of 1000 mg/L, was over 90%. Under electron microscope, RGDFOC12-DTX fat emulsion particles were uniformly spherical. In vitro release test showed that RGDFOC12-DTX fat emulsion showed sustained release. In vitro antitumor activity test showed that RGDFOC12-DTX fat emulsion had obvious time-dependent effect on each cell line and showed sustained release. In vivo antitumor activity test showed that RGDFOC12-DTX fat emulsion had better antitumor activity. Conclusion A new dosage form and preparation method of RGDFOC12-DTX fat emulsion are reported in this paper. the dosage form can effectively increase the stability of the drug, reduce the irritation during injection, enhance the compliance of the body, and has sustained release and better antitumor activity.
【作者单位】: 首都医科大学化学生物学与药学院药剂系;
【基金】:“十二五”重大新药创制科技重大专项(2011ZX09302-007-01)~~
【分类号】:R943;R96
【参考文献】
相关期刊论文 前5条
1 宋丹丹;梁生康;王江涛;王修林;;稳态荧光探针法研究槐糖脂生物表面活性剂的胶束化行为[J];光谱学与光谱分析;2012年08期
2 季书彪;弓崎;;依托咪酯脂肪乳不同用量对全麻苏醒时间及躁动的影响[J];解放军医药杂志;2013年06期
3 柯筱华;王柏;李江慧;;含药脂肪乳剂的靶向作用研究进展[J];药学进展;2007年02期
4 刘沙;熊非;朱家壁;顾宁;;静脉注射用载药脂肪乳的研究近况[J];药学进展;2010年03期
5 崔纯莹;李曦萌;刘虎;崔国辉;;海豹油阳离子脂肪乳的制备与稳定性研究[J];医药导报;2009年12期
【共引文献】
相关期刊论文 前10条
1 逯荻;任晓文;王博;李洪起;;载药脂肪乳剂的研究进展[J];现代药物与临床;2011年05期
2 冯欣;;丹参酮亚微Ⅱ_A亚乳剂的制备及其HPLC法测定[J];光明中医;2013年11期
3 魏丽莎;季艳霞;康振桥;郑爱萍;;肿瘤靶向纳米制剂研究进展[J];国际药学研究杂志;2014年01期
4 刘金勇;何东平;邹,
本文编号:2504636
本文链接:https://www.wllwen.com/yixuelunwen/yiyaoxuelunwen/2504636.html
最近更新
教材专著